表达NP、M1和嵌合血凝素的病毒载体疫苗在小鼠中诱导广谱流感保护
该研究将嵌合血凝素(cHA)策略与表达核蛋白(NP)和基质蛋白1(M1)的病毒载体策略联用,在小鼠模型中评估对H3N2、H7N9和H10N8等2组流感病毒攻击的保护效果。结果显示联用疫苗比单用任一策略对H3N2攻击提供更强保护,并诱导针对 divergent 2组血凝素、NP和M1的抗体及针对NP和M1的强T细胞反应。
要点
- 表达cHA与NP+M1的病毒载体联用对H3N2攻击的保护优于单用任一策略。
- 联用疫苗诱导针对 divergent 2组血凝素、NP和M1的抗体及NP/M1特异性T细胞反应。
- H3 stalk抗体经两剂cHA即升至高水平,但跨亚型广谱反应需三剂暴露。
核心结论
- 联用不同通用流感疫苗策略可诱导广谱抗体和T细胞反应并增强对流感攻击的保护。
研究设计与样本
- 研究在 mouse model 中评估基于Chimpanzee Adenovirus Oxford 1和Modified Vaccinia Ankara的复制缺陷重组病毒载体表达cHA与NP+M1的疫苗效果。
主要发现
- 表达cHA与NP+M1的载体疫苗对H3N2攻击的保护优于仅表达一组抗原的载体疫苗。
- 疫苗诱导针对 divergent 2组血凝素、NP和M1的抗体反应及针对NP和M1的强T细胞反应。
- H3 stalk抗体经两剂cHA接种后即被 boost 至高水平,但跨亚型强反应需三剂暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Seasonal influenza virus infections cause significant morbidity and mortality every year. Annual influenza virus vaccines are effective but only when well matched with circulating strains. Therefore, there is an urgent need for better vaccines that induce broad protection against drifted seasonal and emerging pandemic influenza viruses. One approach to design such vaccines is based on targeting conserved regions of the influenza virus hemagglutinin. Sequential vaccination with chimeric hemagglutinin constructs can refocus antibody responses towards the conserved immunosubdominant stalk domain of the hemagglutinin, rather than the variable immunodominant head. A complementary approach for a universal influenza A virus vaccine is to induce T-cell responses to conserved internal influenza virus antigens. For this purpose, replication deficient recombinant viral vectors based on Chimpanzee Adenovirus Oxford 1 and Modified Vaccinia Ankara virus are used to express the viral nucleoprotein and the matrix protein 1. In this study, we combined these two strategies and evaluated the efficacy of viral vectors expressing both chimeric hemagglutinin and nucleoprotein plus matrix protein 1 in a mouse model against challenge with group 2 influenza viruses including H3N2, H7N9 and H10N8. We found that vectored vaccines expressing both sets of antigens provided enhanced protection against H3N2 virus challenge when compared to vaccination with viral vectors expressing only one set of antigens. Vaccine induced antibody responses against divergent group 2 hemagglutinins, nucleoprotein and matrix protein 1 as well as robust T-cell responses to the nucleoprotein and matrix protein 1 were detected. Of note, it was observed that while antibodies to the H3 stalk were already boosted to high levels after two vaccinations with chimeric hemagglutinins (cHAs), three exposures were required to induce strong reactivity across subtypes. Overall, these results show that a combinations of different universal influenza virus vaccine strategies can induce broad antibody and T-cell responses and can provide increased protection against influenza.
引用
- Asthagiri Arunkumar G, McMahon M, Pavot V, et al. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice. Vaccine. 2019. PMID: 31399277. doi:10.1016/j.vaccine.2019.07.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。